Psychedelics like psilocybin, MDMA, and ketamine are emerging as promising therapeutic tools for mental health issues. Here's ...

Over 600,000 people worldwide die from mosquito-borne malaria each year, with the majority of these deaths happening among ...

Proven Success for Treatment-Resistant Conditions Many individuals in NYC have turned to ketamine therapy ... These options ...

People suffering from major depressive disorder (MDD) and treatment-resistant depression (TRD) often face challenging ...

Atai Life Sciences N.V. ( (ATAI) ) has released its Q3 earnings. Here is a breakdown of the information Atai Life Sciences N.V. presented to ...

By targeting complex conditions such as treatment-resistant depression, social anxiety disorder and opioid use disorder, Atai aims to address significant gaps in the mental health treatment landscape.

People living with HIV may also have to manage other health conditions like cardiovascular disease, type 2 diabetes, ...

Psilocybin therapy -- used to treat a range of mental health conditions, such as depression, anxiety, and addictions -- can ...

According to a patent review published by the American Chemical Society, the new compounds promise improved stability, ...

Research suggests that CBD may help reduce the symptoms of certain types of anxiety. More recently, a 2022 trial looked at the effects of CBD on treatment-resistant anxiety in young adults.

Epilepsy is a chronic brain condition where nerve cells in the brain send incorrect signals causing seizures Heres how it ...

In terms of anxiety symptoms, 54.5 % of patients exhibited such symptoms prior to CBD treatment, with 71 % showing improvement post-treatment. “Adjunctive CBD treatment in adult patients with ...